Company / Capital Expenditures
LeMaitre Vascular Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$6.8M
FY2025
5-year range
$3.0M / $7.3M
FY2021-FY2025
Trend
-2.6%
vs FY2024
Sector context
#124 of 151
Health Care
What the data says
LeMaitre Vascular's capital expenditures of $7M is lower than 82% of companies in the Health Care sector (FY2025). Capital Expenditures has fluctuated over the past 10 years, ranging from $2M in FY2017 to $7M in FY2023.
Based on SEC 10-K filings.
$7M in FY2025 with a 5-year CAGR of +17.3%.
Declined from $7M to $7M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +31.5%
- 5-Year CAGR
- +17.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 151This company $6.8M Sector average $271.7M
▼
-97.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +17.3%, indicating consistent growth.
- In FY2025, capital expenditures decreased 2.6% year-over-year.
- Ranks #124 out of 151 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2023.
Company context
Key Data Points
- Strong profit margin: 20.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.8M | -2.6% |
| FY2024 | $7.0M | -4.2% |
| FY2023 | $7.3M | +143.6% |
| FY2022 | $3.0M | -20.7% |
| FY2021 | $3.8M | +23.1% |
| FY2020 | $3.1M | -52.4% |
| FY2019 | $6.4M | +125.9% |
| FY2018 | $2.8M | +25.0% |
| FY2017 | $2.3M | -20.0% |
| FY2016 | $2.8M | +4.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026